Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Intravenous Dexamethasone to Enhance Early Recovery in Hip Arthroplasty for Fragility Hip Fracture
TCTR20251218005Phase 2Not yet recruiting
- Sponsor
- N/A
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in hip fracture, postoperative pain, post-operative inflammation, sponsored by N/A. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
hip fracturepostoperative painpost-operative inflammation
Beyond the preview
Go deeper on TCTR20251218005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251218005.